271 related articles for article (PubMed ID: 21556051)
1. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
Chen Z; Zhang C; Wu D; Chen H; Rorick A; Zhang X; Wang Q
EMBO J; 2011 May; 30(12):2405-19. PubMed ID: 21556051
[TBL] [Abstract][Full Text] [Related]
2. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
Liu G; Sprenger C; Wu PJ; Sun S; Uo T; Haugk K; Epilepsia KS; Plymate S
Oncotarget; 2015 Jan; 6(1):288-304. PubMed ID: 25481872
[TBL] [Abstract][Full Text] [Related]
3. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
[TBL] [Abstract][Full Text] [Related]
4. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
[TBL] [Abstract][Full Text] [Related]
5. CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
Rasool RU; Natesan R; Deng Q; Aras S; Lal P; Sander Effron S; Mitchell-Velasquez E; Posimo JM; Carskadon S; Baca SC; Pomerantz MM; Siddiqui J; Schwartz LE; Lee DJ; Palanisamy N; Narla G; Den RB; Freedman ML; Brady DC; Asangani IA
Cancer Discov; 2019 Nov; 9(11):1538-1555. PubMed ID: 31466944
[TBL] [Abstract][Full Text] [Related]
6. ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
Jin F; Irshad S; Yu W; Belakavadi M; Chekmareva M; Ittmann MM; Abate-Shen C; Fondell JD
Mol Cancer Res; 2013 Jul; 11(7):736-47. PubMed ID: 23538858
[TBL] [Abstract][Full Text] [Related]
7. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
Hu R; Lu C; Mostaghel EA; Yegnasubramanian S; Gurel M; Tannahill C; Edwards J; Isaacs WB; Nelson PS; Bluemn E; Plymate SR; Luo J
Cancer Res; 2012 Jul; 72(14):3457-62. PubMed ID: 22710436
[TBL] [Abstract][Full Text] [Related]
8. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
[TBL] [Abstract][Full Text] [Related]
9. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
[TBL] [Abstract][Full Text] [Related]
10. Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1.
Russo JW; Nouri M; Balk SP
Cancer Discov; 2019 Nov; 9(11):1490-1492. PubMed ID: 31676563
[TBL] [Abstract][Full Text] [Related]
11. Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.
Hall DD; Spitler KM; Grueter CE
Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H314-H325. PubMed ID: 30461303
[TBL] [Abstract][Full Text] [Related]
12. Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.
Jin F; Claessens F; Fondell JD
J Biol Chem; 2012 Jan; 287(2):858-70. PubMed ID: 22102282
[TBL] [Abstract][Full Text] [Related]
13. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
[TBL] [Abstract][Full Text] [Related]
15. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
Zhao Y; Wang L; Ren S; Wang L; Blackburn PR; McNulty MS; Gao X; Qiao M; Vessella RL; Kohli M; Zhang J; Karnes RJ; Tindall DJ; Kim Y; MacLeod R; Ekker SC; Kang T; Sun Y; Huang H
Cell Rep; 2016 Apr; 15(3):599-610. PubMed ID: 27068475
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
[TBL] [Abstract][Full Text] [Related]
17. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
[TBL] [Abstract][Full Text] [Related]
18. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
[TBL] [Abstract][Full Text] [Related]
19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
20. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]